Evidence map›Paper›PMID 40911191›Full record

ReviewInnere Medizin (Heidelberg, Germany)2025

[Frailty in oncogeriatrics].

Nina Rosa Neuendorff, Rainer Wirth, Barbara Deschler-Baier

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Innere Medizin (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nina Rosa NeuendorffKlinik für Altersmedizin und Frührehabilitation, Marien Hospital Herne, Klinikum der Ruhr-Universität Bochum, Hölkeskampring 40, 44625, Herne, Deutschland. ninarosa.neuendorff@elisabethgruppe.de.
Rainer WirthKlinik für Altersmedizin und Frührehabilitation, Marien Hospital Herne, Klinikum der Ruhr-Universität Bochum, Hölkeskampring 40, 44625, Herne, Deutschland.
Barbara Deschler-BaierComprehensive Cancer Center, Universitätsklinik Würzburg, Würzburg, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Frailty is a common geriatric syndrome in older patients with cancer. It affects prognosis and treatment tolerance in various ways. Frailty and cancer share several common risk factors, which are reflected in the hallmarks of aging. An oncogeriatric assessment with management (GAME) provides the opportunity to detect frailty and its related geriatric impairments and offers the possibility to compensate for frailty-associated vulnerability. Thus, higher-grade treatment-associated toxicities of the provided oncological treatments are reduced. Furthermore, treatment completion rates and quality of life can be improved by GAME. The following review article provides an overview of the general definition of physical and social frailty, its significance in oncology, and the evidence for GAME. Lastly, first study results of frailty-adapted treatment approaches are summarized.

Indexed as

Frail ElderlyFrailtyGeriatric AssessmentNeoplasmsAgedAged, 80 and overHumansPrognosisQuality of LifeRisk FactorsCancerFrail older adultsGeriatric assessmentOncologyTreatment tolerance

Identifiers

PMID40911191

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.